DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

FINISHED DOSAGE FORMULATIONS

1 FDF Dossiers, 1 FDA Orange Book

1 FDF Dossiers
1 FDA Orange Book

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Neotect, Technetium tc 99m depreotide, Technetium tc-99m depreotide, 9m48m2sf02, 174900-52-8, Unii-9m48m2sf02

Molecular Formula

C₆₅H₉₆N₁₆O₁₂S₂Tc

Molecular Weight

1454.6 g/mol

InChI Key

MCEOYGQHDKBYFT-KTABZWLNSA-N

FDA UNII

9M48M2SF02

Technetium tc-99m depreotide is a Radioactive Diagnostic Agent. The mechanism of action of technetium tc-99m depreotide is as a Radiopharmaceutical Activity.

1 2D Structure

Technetium Tc 99M Depreotide

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(2S)-6-amino-2-[[(2R)-2-[[(2S)-6-amino-2-[[(2S)-2-amino-3-[[2-[2-[(2S,5S,8S,11R,14S,17S)-14-(4-aminobutyl)-5-benzyl-8-[(4-hydroxyphenyl)methyl]-11-(1H-indol-3-ylmethyl)-4-methyl-3,6,9,12,15,18-hexaoxo-17-propan-2-yl-1,4,7,10,13,16-hexazacyclooctadec-2-yl]ethylsulfanyl]acetyl]amino]propanoyl]amino]hexanoyl]amino]-3-sulfanylpropanoyl]amino]hexanamide;technetium

2.1.2 InChI

InChI=1S/C65H96N16O12S2.Tc/c1-38(2)55-64(92)76-49(26-30-95-37-54(83)72-35-44(69)57(85)74-47(20-10-13-28-67)58(86)79-52(36-94)62(90)73-46(56(70)84)19-9-12-27-66)65(93)81(3)53(32-39-15-5-4-6-16-39)63(91)78-50(31-40-22-24-42(82)25-23-40)60(88)77-51(33-41-34-71-45-18-8-7-17-43(41)45)61(89)75-48(59(87)80-55)21-11-14-29-68;/h4-8,15-18,22-25,34,38,44,46-53,55,71,82,94H,9-14,19-21,26-33,35-37,66-69H2,1-3H3,(H2,70,84)(H,72,83)(H,73,90)(H,74,85)(H,75,89)(H,76,92)(H,77,88)(H,78,91)(H,79,86)(H,80,87);/t44-,46-,47-,48-,49-,50-,51+,52-,53-,55-;/m0./s1

2.1.3 InChI Key

MCEOYGQHDKBYFT-KTABZWLNSA-N

2.1.4 Canonical SMILES

CC(C)C1C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)CC5=CC=CC=C5)C)CCSCC(=O)NCC(C(=O)NC(CCCCN)C(=O)NC(CS)C(=O)NC(CCCCN)C(=O)N)N.[Tc]

2.1.5 Isomeric SMILES

CC(C)[C@H]1C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)CC5=CC=CC=C5)C)CCSCC(=O)NC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N)N.[Tc]

2.2 Other Identifiers

2.2.1 UNII

9M48M2SF02

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Neotec

2. Tc-99m Depreotide

3. Technetium Tc 99m Depreotide

2.3.2 Depositor-Supplied Synonyms

1. Neotect

2. Technetium Tc 99m Depreotide

3. Technetium Tc-99m Depreotide

4. 9m48m2sf02

5. 174900-52-8

6. Unii-9m48m2sf02

7. Neotec

8. Tc-99m Depreotide

9. Technetium Tc 99m Depreotide [who-dd]

10. Technetium Tc 99m Depreotide [usp Impurity]

11. Technetium Tc-99m Depreotide [orange Book]

12. Q27272728

13. Technetium-99tc, (cyclo(l-homocysteinyl-n-methyl-l-phenylalanyl-l-tyrosyl-d-tryptophyl-l-lysyl-l-valyl) (1-1')-thioether With 3-((mercaptoacetyl)amino)-l-alanyl-l-lysyl-l-cysteinyl-l-lysinamidato(3-))oxo-, (sp-5-24)-

14. Technetium-99tc, (cyclo(l-homocysteinyl-n-methyl-l-phenylalanyl-l-tyrosyl-d-tryptophyl-l-lysyl-l-valyl)(1-1')-sulfide With 3-((mercaptoacetyl)amino)-l-alanyl-l-lysyl-l-cysteinyl-l-lysinamidato(3-))oxo-, (sp-5-24)-

2.4 Create Date

2014-03-02

3 Chemical and Physical Properties

Molecular Formula	C₆₅H₉₆N₁₆O₁₂S₂Tc
Molecular Weight	1454.6 g/mol
Hydrogen Bond Donor Count	17
Hydrogen Bond Acceptor Count	18
Rotatable Bond Count	34
Exact Mass	1453.58987 g/mol
Monoisotopic Mass	1453.58987 g/mol
Topological Polar Surface Area	492 Å²
Heavy Atom Count	96
Formal Charge	0
Complexity	2490
Isotope Atom Count	0
Defined Atom Stereocenter Count	10
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2

4 Drug and Medication Information

4.1 Drug Indication

This medicinal product is for diagnostic use only.

For scintigraphic imaging of suspected malignant tumours in the lung after initial detection, in

combination with CT scan or chest X-ray, in patients with solitary pulmonary nodules.

5 Pharmacology and Biochemistry

5.1 FDA Pharmacological Classification

5.1.1 Active Moiety

TECHNETIUM TC-99M DEPREOTIDE

5.1.2 FDA UNII

9M48M2SF02

5.1.3 Pharmacological Classes

Mechanisms of Action [MoA] - Radiopharmaceutical Activity

5.2 ATC Code

V09IA05

FDF Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Find Technetium Tc 99M Depreotide manufacturers, exporters & distributors on PharmaCompass

Technetium Tc 99M Depreotide

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

FINISHED DOSAGE FORMULATIONS

1 FDF Dossiers

1 FDA Orange Book

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

What are you looking for?